Healthcare -
Biotechnology - NASDAQ - US
$ 2.85
-5.94 %
$ 182 M
Market Cap
-2.48
P/E
LRMR - TOTAL EQUITY
Total Equity LRMR - Larimar Therapeutics, Inc.
81.7 M
LAST VALUE
12.64%
2 YEAR CAGR
-2.61%
5 YEAR CAGR
8.78%
10 YEAR CAGR